Axsome Therapeutics
Biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders.
About
Axsome Therapeutics is a commercial-stage biopharmaceutical company focused on developing and delivering innovative therapies for central nervous system (CNS) conditions. The company leverages a multi-mechanistic approach and the 505(b)(2) regulatory pathway to address significant unmet medical needs in areas such as depression, Alzheimer's disease, and narcolepsy.
Technology stack
detected 2026-06-17Est. monthly stack spend~$180/mo
CDN
Cloudflare
Email
Microsoft 365
Stack
jQuery
WordPress
Analytics
Google Tag Manager
SEO
Yoast SEO
Cookie consent
OneTrust
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does Axsome Therapeutics do?
Axsome Therapeutics is a commercial-stage biopharmaceutical company focused on developing and delivering innovative therapies for central nervous system (CNS) conditions. The company leverages a multi-mechanistic approach and the 505(b)(2) regulatory pathway to address significant unmet medical needs in areas such as depression, Alzheimer's disease, and narcolepsy.
Where is Axsome Therapeutics headquartered?
Axsome Therapeutics is headquartered in New York, United States.
When was Axsome Therapeutics founded?
Axsome Therapeutics was founded in 2012.
What industry does Axsome Therapeutics operate in?
Axsome Therapeutics operates in Biotech, Pharmaceuticals, Healthcare.